Lescarden Inc.
OTC: LCAR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- William E. Luther
- Employees
- 1
- Headquarters
- New York City, United States
- IPO year
- 1999
- Market cap
- $3.2K
- Website
- https://www.lescarden.com
Loading LCAR…
Loading profile data…Frequently asked questions about LCAR
What does Lescarden Inc. (LCAR) do?
Lescarden Inc. operates as a pharmaceutical company, concentrating on the investigation, refinement, and market distribution of medicinal products aimed at managing and curing various illnesses. Its global reach extends across the United States, Europe, and South Korea. The company's premier offering is Catrix Wound Dressing, a product specifica...
Where does LCAR trade?
Lescarden Inc. (LCAR) trades on the Other OTC.
What sector is LCAR in?
Lescarden Inc. (LCAR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Lescarden Inc.?
William E. Luther is the chief executive officer of Lescarden Inc. (LCAR).
Where is Lescarden Inc. headquartered?
Lescarden Inc. is headquartered in United States.
Does LCAR pay a dividend?
Lescarden Inc. (LCAR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LCAR go public?
Lescarden Inc. (LCAR) completed its initial public offering in 1999.